Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

US Patent 8920800 · Granted Dec 30, 2014

Estimated economic value: $9,577,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low dose combination CDA substrate drug/cedazuridine with extended administratio2023
Low dose combination CDA substrate drug/cedazuridine with extended administratio2022
Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins2016
Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins2013